Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Biliary Tract Neoplasms × Cetuximab × Clear all

Phase

Phase 1/2 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 129 Head and Neck Neoplasms 68 Squamous Cell Carcinoma of Head and Neck 64 Rectal Neoplasms 41 Colonic Neoplasms 36 Carcinoma, Non-Small-Cell Lung 32 Neoplasm Metastasis 30 Neoplasms 21 Carcinoma, Squamous Cell 19 Pancreatic Neoplasms 15 Lung Neoplasms 14 Esophageal Neoplasms 14 Stomach Neoplasms 12 Laryngeal Neoplasms 11 Recurrence 10 Mouth Neoplasms 9 Esophageal Squamous Cell Carcinoma 8 Breast Neoplasms 8 Adenocarcinoma Of Esophagus 8 Tongue Neoplasms 7 Oropharyngeal Neoplasms 7 Hypopharyngeal Neoplasms 6 Colorectal Cancer Metastatic 6 Adenocarcinoma of Lung 6 Uterine Cervical Neoplasms 5 Salivary Gland Neoplasms 5 Nasopharyngeal Carcinoma 5 Laryngeal Diseases 5 Carcinoma 4 Adenocarcinoma, Bronchiolo-Alveolar 4

Interventions

Gemcitabine 38 Cisplatin 30 Oxaliplatin 20 Capecitabine 16 Leucovorin 13 Fluorouracil 13 pembrolizumab 10 lenvatinib 10 durvalumab 10 Irinotecan 10 S 1 (combination) 7 Bevacizumab 7 tremelimumab 6 apatinib 5 Nivolumab 5 Trastuzumab 4 Injections 4 Docetaxel 4 trametinib 3 titanium silicide 3 irinotecan sucrosofate 3 envafolimab 3 camrelizumab 3 atezolizumab 3 Drug Therapy 3 zanidatamab 2 toripalimab 2 tislelizumab 2 surufatinib 2 pertuzumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01267344 2016-05-04

BTC

National Health Research Institutes, Taiwan

Phase 2 Completed

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡